Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ENT Fellow
    ENT Fellow
    • May 2013
    • 10

    Very Low Coverage NGS Copy Number analysis

    Hi all,

    I'm doing very low coverage sequencing using the Illumina HiSeq running 40/lane looking at DNA copy number in FFPE head and neck cancer samples. I've been using CNAnorm to analyse the data, create karyograms etc. as this seemed to be specifically designed with low coverage NGS in mind and has ben published in cancer studies.

    With so many software packages available does anyone have any experience of other packages with specifically this low coverage NGS in FFPE DNA CNV? I'm a bit concerned at having to defend the choice in my viva.

    many thanks
  • ni16
    Junior Member
    • Jan 2016
    • 3

    #2
    Hi ENT Fellow,
    What if alongside some low coverage area, I want to know copy number of higher coverage area, would you expect CNAnorm to equally good, or you see some issues with the tool?

    Comment

    • Richard Finney
      Senior Member
      • Feb 2009
      • 701

      #3
      I've used bic-seq2 with low coverage with good results.
      Note that you need to adjust lambda parameter for low coverage samples.
      It's a bit of hassle to setup and get going.

      Comment

      • Brian Bushnell
        Super Moderator
        • Jan 2014
        • 2709

        #4
        I originally developed BBMap for a lab with very low-quality and low-coverage data. Not specifically for karyotyping, but for identifying mutations in low-coverage data, by rigorously optimizing the true/false positive/negative rates in low-coverage data. As such, it tries very hard to make the most of all input data.

        BBMap does not do karyotyping, directly, though it can directly output coverage information. But it is extremely accurate in the presence of rampant mutations - including 100kbp+ deletions, which might erase an entire suppressor gene - and as such, is ideal for cancer experiments. The ability to directly output per-base coverage might be helpful as well.

        Comment

        • zajic
          Junior Member
          • Jul 2014
          • 2

          #5
          Very Low Coverage NGS Copy Number analysis

          Hi, I used 2 R libraries: QDNAseq and ReadDepth. Both seem to have similar results.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          152 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          62 views
          0 reactions
          Last Post SEQadmin2  
          Working...